BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12124349)

  • 1. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma.
    Landen JW; Lang R; McMahon SJ; Rusan NM; Yvon AM; Adams AW; Sorcinelli MD; Campbell R; Bonaccorsi P; Ansel JC; Archer DR; Wadsworth P; Armstrong CA; Joshi HC
    Cancer Res; 2002 Jul; 62(14):4109-14. PubMed ID: 12124349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noscapine crosses the blood-brain barrier and inhibits glioblastoma growth.
    Landen JW; Hau V; Wang M; Davis T; Ciliax B; Wainer BH; Van Meir EG; Glass JD; Joshi HC; Archer DR
    Clin Cancer Res; 2004 Aug; 10(15):5187-201. PubMed ID: 15297423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of microtubule-interfering halogenated noscapine analogs that perturb mitosis in cancer cells followed by cell death.
    Aneja R; Vangapandu SN; Lopus M; Viswesarappa VG; Dhiman N; Verma A; Chandra R; Panda D; Joshi HC
    Biochem Pharmacol; 2006 Aug; 72(4):415-26. PubMed ID: 16780803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model.
    Barken I; Geller J; Rogosnitzky M
    Anticancer Res; 2008; 28(6A):3701-4. PubMed ID: 19189652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
    Madari H; Panda D; Wilson L; Jacobs RS
    Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses.
    Ke Y; Ye K; Grossniklaus HE; Archer DR; Joshi HC; Kapp JA
    Cancer Immunol Immunother; 2000 Jul; 49(4-5):217-25. PubMed ID: 10941904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of the microtubule-targeting anti-breast cancer drug EM015.
    Aneja R; Lopus M; Zhou J; Vangapandu SN; Ghaleb A; Yao J; Nettles JH; Zhou B; Gupta M; Panda D; Chandra R; Joshi HC
    Cancer Res; 2006 Apr; 66(7):3782-91. PubMed ID: 16585205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
    Suggitt M; Swaine DJ; Pettit GR; Bibby MC
    Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
    Zhou J; Gupta K; Aggarwal S; Aneja R; Chandra R; Panda D; Joshi HC
    Mol Pharmacol; 2003 Apr; 63(4):799-807. PubMed ID: 12644580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells.
    Ye K; Ke Y; Keshava N; Shanks J; Kapp JA; Tekmal RR; Petros J; Joshi HC
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1601-6. PubMed ID: 9465062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
    Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
    Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
    Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F; Discafani CM; Annable T; Beyer C; Musto S; Hari M; Tan X; Hardy C; Hernandez R; Baxter M; Singanallore T; Khafizova G; Poruchynsky MS; Fojo T; Nieman JA; Ayral-Kaloustian S; Zask A; Andersen RJ; Greenberger LM
    Cancer Res; 2003 Apr; 63(8):1838-45. PubMed ID: 12702571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model.
    Yang H; Xu Z; Iuvone PM; Grossniklaus HE
    Mol Vis; 2006 May; 12():511-7. PubMed ID: 16735992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel and improved antimitotic agents derived from noscapine.
    Anderson JT; Ting AE; Boozer S; Brunden KR; Crumrine C; Danzig J; Dent T; Faga L; Harrington JJ; Hodnick WF; Murphy SM; Pawlowski G; Perry R; Raber A; Rundlett SE; Stricker-Krongrad A; Wang J; Bennani YL
    J Med Chem; 2005 Nov; 48(23):7096-8. PubMed ID: 16279766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
    Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
    Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK; Chiu P; Chung SS; Chow LM; Zhao YZ; Yang BB; Ko BC
    Clin Cancer Res; 2005 Aug; 11(16):6002-11. PubMed ID: 16115945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumoural activity of peripheral blood mononuclear cells against melanoma cells: discrepant in-vitro and in-vivo effects.
    Joseph-Pietras D; Carlier A; Madoulet C; Albert P
    Melanoma Res; 2006 Aug; 16(4):325-33. PubMed ID: 16845328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.